Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) Gross Margin (2020 - 2022)

iBio (IBIO) has disclosed Gross Margin for 3 consecutive years, with 105.28% as the latest value for Q1 2022.

  • On a quarterly basis, Gross Margin rose 13038.0% to 105.28% in Q1 2022 year-over-year; TTM through Jun 2022 was 115.02%, a 7668.0% increase, with the full-year FY2022 number at 115.02%, up 7668.0% from a year prior.
  • Gross Margin was 105.28% for Q1 2022 at iBio, down from 203.57% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 203.57% in Q3 2021 to a low of 25.1% in Q1 2021.
  • A 3-year average of 71.67% and a median of 71.69% in 2020 define the central range for Gross Margin.
  • Peak YoY movement for Gross Margin: crashed -3551bps in 2021, then skyrocketed 13038bps in 2022.
  • iBio's Gross Margin stood at 70.07% in 2020, then surged by 191bps to 203.57% in 2021, then crashed by -48bps to 105.28% in 2022.
  • Per Business Quant, the three most recent readings for IBIO's Gross Margin are 105.28% (Q1 2022), 203.57% (Q3 2021), and 61.91% (Q2 2021).